303 related articles for article (PubMed ID: 24848364)
1. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
Miguel TT; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway.
Bertagna NB; Dos Santos PGC; Queiroz RM; Fernandes GJD; Cruz FC; Miguel TT
Pharmacol Rep; 2021 Feb; 73(1):57-72. PubMed ID: 33175366
[TBL] [Abstract][Full Text] [Related]
3. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
Cipriano AC; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
[TBL] [Abstract][Full Text] [Related]
4. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
5. Anxiety-like responses induced by nitric oxide within the BNST in mice: Role of CRF1 and NMDA receptors.
Faria MP; Miguel TT; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 Mar; 79():74-83. PubMed ID: 26774463
[TBL] [Abstract][Full Text] [Related]
6. Anxiogenesis induced by social defeat in male mice: Role of nitric oxide, NMDA, and CRF
Faria MP; Laverde CF; Nunes-de-Souza RL
Neuropharmacology; 2020 Apr; 166():107973. PubMed ID: 32006904
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive Dysfunction.
Uribe-Mariño A; Gassen NC; Wiesbeck MF; Balsevich G; Santarelli S; Solfrank B; Dournes C; Fries GR; Masana M; Labermeier C; Wang XD; Hafner K; Schmid B; Rein T; Chen A; Deussing JM; Schmidt MV
Biol Psychiatry; 2016 Nov; 80(10):743-753. PubMed ID: 27318500
[TBL] [Abstract][Full Text] [Related]
8. Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice.
Pentkowski NS; Tovote P; Zavala AR; Litvin Y; Blanchard DC; Spiess J; Blanchard RJ
Horm Behav; 2013 Aug; 64(3):519-26. PubMed ID: 23845323
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Manipulation of Corticotropin-Releasing Factor Receptors in the Anterior and Posterior Subregions of the Insular Cortex Differently Affects Anxiety-Like Behaviors in the Elevated Plus Maze in Rats.
Lopes LM; Reis-Silva LL; Rodrigues B; Crestani CC
Biomed Res Int; 2024; 2024():8322844. PubMed ID: 38327803
[TBL] [Abstract][Full Text] [Related]
10. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
Sergio Tde O; Spiacci A; Zangrossi H
Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
[TBL] [Abstract][Full Text] [Related]
11. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
12. Microinjection of different doses of corticotropin-releasing factor into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats.
Ohata H; Shibasaki T
J Nippon Med Sch; 2011; 78(5):286-92. PubMed ID: 22041875
[TBL] [Abstract][Full Text] [Related]
13. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.
Sahuque LL; Kullberg EF; Mcgeehan AJ; Kinder JR; Hicks MP; Blanton MG; Janak PH; Olive MF
Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282
[TBL] [Abstract][Full Text] [Related]
14. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
Solati J; Salari AA; Bakhtiari A
Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
[TBL] [Abstract][Full Text] [Related]
15. A role of noradrenergic receptors in anxiolytic-like effect of high CRF in the rat frontal cortex.
Śmiałowska M; Zięba B; Domin H
Neuropeptides; 2021 Aug; 88():102162. PubMed ID: 34062382
[TBL] [Abstract][Full Text] [Related]
16. Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
Jonassen AK; Wergeland A; Helgeland E; Mjøs OD; Brar BK
Regul Pept; 2012 Feb; 174(1-3):90-7. PubMed ID: 22209828
[TBL] [Abstract][Full Text] [Related]
17. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
18. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor infusion into nucleus incertus suppresses medial prefrontal cortical activity and hippocampo-medial prefrontal cortical long-term potentiation.
Farooq U; Rajkumar R; Sukumaran S; Wu Y; Tan WH; Dawe GS
Eur J Neurosci; 2013 Aug; 38(4):2516-25. PubMed ID: 23668693
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration.
Orozco-Cabal L; Liu J; Pollandt S; Schmidt K; Shinnick-Gallagher P; Gallagher JP
J Neurosci; 2008 Jan; 28(2):529-42. PubMed ID: 18184795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
